Mangalam Drugs & Organics Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 870.03 million compared to INR 1,094.66 million a year ago. Revenue was INR 874.68 million compared to INR 1,094.95 million a year ago.

Net loss was INR 95.35 million compared to net income of INR 30.04 million a year ago. Basic loss per share from continuing operations was INR 6.02 compared to basic earnings per share from continuing operations of INR 1.9 a year ago. Diluted loss per share from continuing operations was INR 6.02 compared to diluted earnings per share from continuing operations of INR 1.9 a year ago.